FDA.reportPublic FDA data

linagliptin 5 MG / metformin HCl 1000 MG 24HR Extended Release Oral Tablet

RxCUI
1796094
RxNorm name
linagliptin 5 MG / metformin HCl 1000 MG 24HR Extended Release Oral Tablet
Display name
linagliptin 5 MG / metformin HCl 1000 MG 24HR Extended Release Oral Tablet
Full name
linagliptin 5 MG / metformin HCl 1000 MG 24HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Jentadueto XRLINAGLIPTIN AND METFORMIN HYDROCHLORIDEBoehringer Ingelheim Pharmaceuticals, Inc.3d02a4d4-d312-80b4-05c4-691b8f0aa7aa2024-05-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1796094

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
3d02a4d4-d312-80b4-05c4-691b8f0aa7aalinagliptin 5 MG / metformin HCl 1000 MG 24HR Extended Release Oral TabletSY9These highlights do not include all the information needed to use JENTADUETO XR safely and effectively. See full prescribing information for JENTADUETO XR. JENTADUETO ® XR (linagliptin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 201220240524
3d02a4d4-d312-80b4-05c4-691b8f0aa7aalinagliptin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral TabletPSN9These highlights do not include all the information needed to use JENTADUETO XR safely and effectively. See full prescribing information for JENTADUETO XR. JENTADUETO ® XR (linagliptin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 201220240524
3d02a4d4-d312-80b4-05c4-691b8f0aa7aa24 HR linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral TabletSCD9These highlights do not include all the information needed to use JENTADUETO XR safely and effectively. See full prescribing information for JENTADUETO XR. JENTADUETO ® XR (linagliptin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 201220240524